Bacillus coagulans: strains and forms
How to distinguish B. coagulans strains, live cells and inactivated cells.
Key points
- Unique IS2, MTCC 5856, IDCC 1201, BC99 and SANK70258 are different strains with separate studies. Check the exact code and composition: a result for one strain does not describe a blend with fiber. [1] [2] [3] [4] [5] [6] [7] [8] [9] See the evidence 1
- In adults with regular bloating and gas, MTCC 5856 reduced the combined score for bloating, belching and gas over four weeks by 5.85 points versus 1.09 with placebo on a scale up to 18. This is a result for a specific strain and group. [8] See the evidence 1
- For a live product, check the CFU count through the end of shelf life and storage conditions; a higher number alone does not mean a greater effect. Inactivated cells are not a dose of live probiotic. [1] [2] [3] [4] [5] [6] [7] [8] [9] See the evidence 1
Practical guide
Check the findings and their applicability to your situation.
The studies concern a specific strain, dose and product composition.
Key points
Why these conclusions
Strains and forms
The strains have separate studies. Inactivated cells contain no live bacteria, and their cell count is not considered a dose of live probiotic. [1] [2] [3] [4] [5] [6] [7] [8] [9]
Adults with regular bloating and gas took 2 billion viable spores of MTCC 5856 daily or placebo for four weeks. The combined score for three complaints fell by 5.85 versus 1.09 points out of 18; certainty is low — 2 out of 4. [8]
GBI-30, 6086 spores may be added to food products; the product name alone does not establish the presence of the strain. Check the label: food-associated GBI-30, 6086 differs from the strains in the results table. [10] [6]
Information from the source
| Name | Description | Sources |
|---|---|---|
| Strain and number of live bacteria | Unique IS2, MTCC 5856, IDCC 1201, BC99 and SANK70258 have different studies. When choosing, the full strain name, CFU count through the end of shelf life and storage conditions on the label are important. A higher CFU count alone does not mean a greater effect. | [5] [2] [8] [4] [7] [1] [3] [6] |
| Live and nonliving cells | Inactivated cells contain no live bacteria. Their cell count cannot be considered a dose of live probiotic, nor can results from trials of live strains be transferred to them. | [9] [6] |
| Sports option | Unique IS2 was studied together with 20 g of whey powder daily and resistance training. The available description does not specify whether the probiotic itself was in a capsule or powder. | [1] |
Information from the source
GBI-30, 6086 spores may be added to drinks, juices, dairy products, their plant-based alternatives, breakfast foods and baked goods. Check the label for the presence and amount of the culture. The product name alone — yogurt, for example — does not mean it contains this strain. Food-associated GBI-30, 6086 differs from the strains in the results table. There is no established daily dietary requirement or general tolerable upper level for this bacterium. The amount in a product and doses from individual trials are not such a requirement. [10] [6]
Information from the source
Gas and digestive discomfort are possible. In the MTCC 5856 study, one participant experienced short-lived heartburn and nausea. In the sports study, one participant in the supplement group withdrew because of vomiting and loose stools; there was also a withdrawal in the placebo group because of vomiting and discomfort. This alone does not prove that the probiotic was the cause. In cases of severe illness or weakened immunity, discuss the choice of a live probiotic with a doctor: infections associated with probiotic microorganisms have been described in vulnerable people. Preterm infants are a particularly vulnerable group. These risks concern probiotics in general; their frequency for a specific strain is not assessed here. The sports study used whey milk protein; the powder contained lactose, and lactose was added instead of the probiotic in the comparison group. If you have a milk protein allergy or lactose intolerance, check the entire product composition. [1] [6] [8]
The combined score for bloating, belching and gas on a scale from 0 to 18 fell from 8.91 to 3.06 points on the supplement and from 9.42 to 8.33 on placebo. This is a decrease of 5.85 versus 1.09 points (p<0.001).
| Parameter | Data |
|---|---|
| Result | The combined score for bloating, belching and gas on a scale from 0 to 18 fell from 8.91 to 3.06 points on the supplement and from 9.42 to 8.33 on placebo. This is a decrease of 5.85 versus 1.09 points (p<0.001). |
| Participants | 70 adults aged 18–65 with regular bloating and gas; 66 completed the study, 33 per group. IBS, functional constipation, lactose intolerance and functional dyspepsia were excluded. |
| Form | MTCC 5856 (LactoSpore): 410 mg tablet containing viable spores |
| Dose | 2 billion viable spores in one tablet daily, 30 minutes before the morning meal |
| Dose basis | 2 billion viable spores in one tablet daily, 30 minutes before the morning meal |
| Comparison | Placebo tablet with maltodextrin and the same excipients |
| Duration | 4 weeks; final assessment on day 30 |
| Certainty | 2/4: One small study, analyzing 66 of 70 participants. Several subjective complaints were studied. The result concerns bloating, belching and gas in the specified group. |
| Body of evidence | 1 publication described |
| Sources | [8] |
Sources
- The effect of Bacillus coagulans Unique IS-2 supplementation on plasma amino acid levels and muscle strength in resistance trained males consuming whey protein: a double-blind, placebo-controlled study. https://pubmed.ncbi.nlm.nih.gov/35249118/
- Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial. https://pubmed.ncbi.nlm.nih.gov/40456531/
- Improvement of skin condition and intestinal microbiota via Heyndrickxia coagulans SANK70258 intake: A placebo-controlled, randomized, double-blind, parallel-group comparative study. https://pubmed.ncbi.nlm.nih.gov/39127017/
- Efficacy and Safety of Bacillus coagulans IDCC 1201 for Sleep Improvement in Adults with Sleep Disturbance: A Randomized, Double-Blind, Placebo-Controlled Polysomnographic Study. https://pubmed.ncbi.nlm.nih.gov/42196985/
- Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. https://pubmed.ncbi.nlm.nih.gov/31434935/
- Probiotics — Health Professional Fact Sheet (NIH ODS). https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
- Effect of Bacillus coagulans BC99 supplementation on body weight and gut microbiota in overweight and obese individual: a randomized, double-blind, placebo-controlled study. https://pubmed.ncbi.nlm.nih.gov/40416368/
- The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study. https://pubmed.ncbi.nlm.nih.gov/36862903/
- GRAS Notice 670: Inactivated Bacillus coagulans GBI-30, 6086. https://www.fda.gov/media/100803/download
- FDA GRAS Notice No. 399: Bacillus coagulans GBI-30, 6086 spores. https://hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=399
Methodology: Subpages evidence-led supplement pipeline v1